Monophasic HA dermal filler (fine-line / superficial dermis correction)
Certifications
CE certified (manufacturer product brochure and JDBIO product pages state CE certification and ISO 13485 compliance)
Manufacturer states HCCL™ process minimises residual BDDE and uses controlled cross Linking technology (manufacturer claim in product literature)
Manufacturer cites clinical testing and comparative clinical trial data in promotional brochure (manufacturer Provided clinical summary statements)
CE certified (manufacturer product brochure and JDBIO product pages state CE certification and ISO 13485 compliance)
Manufacturer states HCCL™ process minimises residual BDDE and uses controlled cross Linking technology (manufacturer claim in product literature)
Manufacturer cites clinical testing and comparative clinical trial data in promotional brochure (manufacturer Provided clinical summary statements)
Monophasic HA dermal filler (fine-line / superficial dermis correction)
Description
TEOFIL Classic is a CE-certified, monophasic cross-linked hyaluronic acid (HA) dermal filler developed with HCCL™ (Highly Completed Cross-Linking) technology to provide a stable, consistent gel with enhanced viscoelasticity. Formulated for smoothing fine lines and superficial rhytides, Teofil Classic is supplied as a 1.0 ml syringe containing HA and lidocaine to aid patient comfort. The manufacturer positions Classic for upper-dermal, fine-line correction with a soft, flexible texture for use in delicate facial areas.
Bnefits
Monophasic gel structure providing consistent texture and smooth integration
HCCL™ advanced cross-linking technology for longer-lasting cross-links and reduced pendant BDDE
Contains lidocaine (0.3% / listed by manufacturer) for enhanced patient comfort during injection
20 mg hyaluronic acid per ml concentration for hydration and fine-line smoothing
CE certified and ISO 13485 referenced by manufacturer materials
Packaged for clinical use with included needles (manufacturer pack content described in product literature)
Indications
Smoothing fine lines and wrinkles (upper dermis applications)
Periorbital lines (crow's feet), perioral lines, glabella lines, forehead lines and other fine facial rhytides as listed by manufacturer
Indicated by manufacturer for use in a range of facial areas including tear troughs, lip contouring, nasolabial lines and other aesthetic corrections depending on the Teofil product variant (Classic for fine lines/upper dermis)
Composition
Hyaluronic acid (cross-linked) — 20 mg/ml as stated in manufacturer literature
Lidocaine 0.3% (stated in manufacturer brochure / product summary)
Cross-linking using HCCL™ technology with minimized BDDE (manufacturer description; exact residual BDDE levels not published in brochure)
Monophasic hyaluronic acid gel with enhanced viscoelasticity (soft/fine texture) intended for injection into the upper dermis for smoothing lines
Provided in pre-filled syringe format (manufacturer product summary lists 1 x 1.0 ml syringe for Classic)
Manufacturer pack contents: 1 x 1.0 ml syringe, needles included (examples listed: 1 x 27G needle and 1 x 30G needle in product summary)
Packaging
Typical pack: 1 x 1.0 ml pre-filled syringe (Classic variant) with accompanying needles as indicated in manufacturer product summary
Sterile single-use disposable syringe packaging; carton and leaflet included (pack artwork and exact accessories may vary by region and distributor)
Usage
For professional use only by qualified practitioners trained in injectable dermal fillers (manufacturer states 'Professional Use Only' on distributor pages).
Follow aseptic technique and local protocols for injection depth and technique — Classic is described for upper dermis/superficial placement for fine-line correction (manufacturer product summary).
Massage and aftercare per clinician judgement and local protocol; monitor for immediate complications post-injection.
Follow manufacturer instructions and local regulations for product handling, use of needles, and disposal of sharps.
Contraindications
Not publicly listed
Adverse Effects
Not publicly listed
Storage Conditions
Manufacturer/distributor listings and product literature reference standard storage conditions; one distributor/manufacturer note lists storage at 2–25°C (refrigeration not universally required) — consult product labelling/IFU for final storage instructions.
Keep in original packaging until use to preserve sterility; protect from extreme temperatures and direct sunlight.
Duration
Manufacturer and distributor listings indicate results are expected to be long-lasting; typical duration referenced by some supplier pages is approximately 6\u201312 months depending on individual factors. Exact duration is clinical and patient-dependent and not stated as a fixed guarantee in the manufacturer brochure.
Onset
Not publicly listed (immediate volumising/smoothing effect expected upon injection; manufacturer brochure does not provide a quantified onset time).
